Santhera Pharmaceuticals Holding AG (SWX:SANN)

SWX:SANN Revenue

In the year 2025, Santhera Pharmaceuticals Holding AG had annual revenue of 77.19M CHF with 97.32% growth. Santhera Pharmaceuticals Holding AG had revenue of 53.17M in the half year ending December 31, 2025, a decrease of -46.55%.

• Revenue: 77.19M
• Revenue Growth: +97.32%
• P/S Ratio: 2.75
• Revenue / Employee: 821.12K
• Employees: 94
• Market Cap: 212.07M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	77.19M	38.07M	97.32%
Dec 31, 2024	39.12M	-64.30M	-62.17%
Dec 31, 2023	103.41M	95.94M	1,283.84%
Dec 31, 2022	7.47M	9.07M	-
Dec 31, 2021	-1.60M	-16.60M	-
Dec 31, 2020	15.01M	-60.37M	-80.09%
Dec 31, 2019	75.38M	43.72M	138.10%
Dec 31, 2018	31.66M	8.71M	37.98%
Dec 31, 2017	22.94M	3.91M	20.54%
Dec 31, 2016	19.03M	14.71M	340.48%
Dec 31, 2015	4.32M	1.73M	66.77%
Dec 31, 2014	2.59M	1.27M	96.44%
Dec 31, 2013	1.32M	-2.22M	-62.72%
Dec 31, 2012	3.54M	273.00K	8.36%
Dec 31, 2011	3.27M	-17.34M	-84.16%
Dec 31, 2010	20.61M	-1.73M	-7.74%
Dec 31, 2009	22.34M	22.29M	46,439.58%
Dec 31, 2008	48.00K	-9.18M	-99.48%
Dec 31, 2007	9.23M	8.45M	1,081.31%
Dec 31, 2006	781.00K	-	-
Dec 31, 2005	-	-	-

Data Source: Fiscal.ai Last updated: Apr 27, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 2, 2026

Data Sources Report a data error